Basel, Basel, Switzerland
Early oncology portfolio oversight, providing regulatory expertise to the development organisation for new assets and treatment modalities transitioning from research to clinical stage.
Since Jan 2021 - Leading the Worldwide registration (US, EU, Japan, Rest of the World) of a new CML therapy (new molecular entity), responsible for the regulatory strategy for the compound and coordinating a team of great regulatory managers
French Office (Paris) Therapeutic aera : Cardiology, metabolism, smoking cessation
French office (Paris) Therapeutic aera : Oncology